Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Review Djibouti .
Press releases published on September 19, 2025
NovaQuant Agency Announces Launch of AlphaSynth System Investment Platform and Issuance of NQA Token
Denver, CO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- NovaQuant Agency has officially announced the launch of its AlphaSynth System investment platform together with the issuance of its native digital asset, the NQA Token, marking a significant milestone in the …
Nuvini Group CEO Pierre Schurmann to Participate in Keynote Presentation at Brazil Investment Week in London on September 30, 2025
NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Nuvini Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), a leading technology conglomerate in the Latin American SaaS sector, today announced that Chief Executive Officer Pierre Schurmann will …
Vaxart Announces Withdrawal of Reverse Stock Split Proposal
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, …
Bylvay® (odévixibat) approuvé au Japon pour le traitement d’une maladie rare du foie (CIFP)
Bylvay® est le premier inhibiteur du transport iléal des acides biliaires administré une fois par jour à être approuvé comme traitement du prurit associé à la cholestase intra-hépatique familiale progressive (CIFP) au Japon, offrant une option de …
Bylvay® (odevixibat) approved in Japan for rare liver disease PFIC
Bylvay® is the first once-daily ileal bile acid transport inhibitor to be approved as a treatment for pruritus associated with progressive familial intrahepatic cholestasis (PFIC) in Japan, offering a non-surgical treatment option for infants, young …
Alvotech Announces Marketing Approval in Japan of Three New Biosimilars
REYKJAVIK, Iceland, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its commercialization partner in …
Kraig Biocraft Laboratories Expands Spider Silk Manufacturing with Pursuit of Additional Rearing Center
ANN ARBOR, Mich., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced that it is actively pursuing the acquisition of an additional …
Regeneron Donates Ebola Treatment for Use in Countries Most at Risk of Outbreaks
Inmazeb® (atoltivimab, maftivimab, and odesivimab-ebgn) was the first treatment approved by the U.S. Food and Drug Administration (FDA) for Orthoebolavirus zairense, also known as Zaire ebolavirus Supply is being rushed to Democratic Republic of Congo (DRC …
Skye Presents Phase 1b Data for its Peripheral CB1-inhibiting Antibody, Nimacimab, at European Association for the Study of Diabetes (EASD) Annual Meeting
SAN DIEGO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced the …
Syndax’s Revuforj® (revumenib) Included in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for the Treatment of Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia
NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that the National Comprehensive Cancer Network® (NCCN®) Clinical …
Naoris Protocol Showcases Quantum-Resistant Security at 1640 Society Family Office Wealth Forum & Volcano Innovation Summit
Porto, Portugal / Wilmington, DE , Sept. 19, 2025 (GLOBE NEWSWIRE) -- Naoris Protocol, the first in production quantum-resistant blockchain and cybersecurity mesh architecture, has announced its participation in two high-profile, invitation-only gatherings …
פתרונות ההגנה מפני הונאות מבוססי הבינה המלאכותית של Mavenir זכו בפרס של FutureNet Asia עבור חדשנות בחוויית לקוח
Mavenir זכתה בפרסים המובילים עבור חבילת האבטחה של קול והודעות - זכתה להכרה עבור קידום האמון והבטיחות עבור לקוחות המובייל עם חיסכון חודשי של מעל 500 אלף דולר, חבילת ההונאות של Mavenir מוכיחה את ערכה עבור ספקיות שירותי תקשורת בשכבה 1 ריצ'רדסון, טקסס …
Solusi Pertahanan terhadap Penipuan Berbasis AI Mavenir Memenangkan Penghargaan FutureNet Asia untuk Inovasi Pengalaman Pelanggan
Mavenir meraih penghargaan tertinggi untuk rangkaian solusi keamanan suara dan pesan – diakui atas kemajuan dalam meningkatkan kepercayaan dan keamanan bagi pelanggan layanan seluler Dengan penghematan bulanan lebih dari $500 ribu, rangkaian solusi …
โซลูชันป้องกันการฉ้อโกงที่ขับเคลื่อนด้วย AI ของ Mavenir คว้ารางวัล FutureNet Asia Award…
Mavenir คว้ารางวัลสูงสุดจากชุดการรักษาความปลอดภัยสำหรับเสียงและข้อความ โดยได้รับการยกย่องในด้านการยกระดับความเชื่อมั่นและความปลอดภัยให้แก่ผู้ใช้มือถือ ด้วยการประหยัดกว่า 500,000 ดอลลาร์สหรัฐต่อเดือน ชุดป้องกันการทุจริตของ Mavenir …
Mavenir gewinnt FutureNet Asia Award für KI-gestützte Betrugsschutzlösungen und Innovation in der Kundenerfahrung
Mavenir erhält die höchste Auszeichnung für seine Sicherheitslösung für Sprach- und Nachrichtenübermittlung und wird damit für die Förderung von Vertrauen und Sicherheit bei Mobilfunkkunden geehrt Mit monatlichen Einsparungen von über 500.000 US-Dollar …
Las soluciones de defensa antifraude impulsadas por inteligencia artificial (IA) de Mavenir ganan el premio FutureNet Asia a la innovación en experiencia del cliente
Mavenir se lleva los más altos honores por su suite de seguridad de voz y mensajería, reconocida por promover la confianza y la seguridad de los clientes móviles Con ahorros de más de 500.000 USD al mes, la suite antifraude de Mavenir demuestra su valor …
Les solutions de lutte contre la fraude basées sur l’IA de Mavenir remportent le prix FutureNet Asia dans la catégorie « Innovation en matière d’expérience client »
Mavenir remporte les honneurs pour sa suite de solutions logicielles de sécurité vocale et de messagerie, saluée pour sa capacité à renforcer la confiance et la sécurité des clients de téléphonie mobile En réalisant plus de 500 000 dollars d’économies …